122 related articles for article (PubMed ID: 33923541)
1. A Disintegrin and Metalloprotease 12 Promotes Tumor Progression by Inhibiting Apoptosis in Human Colorectal Cancer.
Park YL; Park SY; Oh HH; Chung MW; Hong JY; Kim KH; Myung DS; Cho SB; Lee WS; Kim HS; Joo YE
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33923541
[TBL] [Abstract][Full Text] [Related]
2. A disintegrin and metalloprotease 12 contributes to colorectal cancer metastasis by regulating epithelial‑mesenchymal transition.
Oh HH; Park YL; Park SY; Joo YE
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36866761
[TBL] [Abstract][Full Text] [Related]
3. Expression of
Chung MW; Park YL; Park SY; Joo YE
In Vivo; 2022; 36(5):2194-2204. PubMed ID: 36099146
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
[TBL] [Abstract][Full Text] [Related]
5. High expression of DJ-1 promotes growth and invasion via the PTEN-AKT pathway and predicts a poor prognosis in colorectal cancer.
Lin Y; Chen Q; Liu QX; Zhou D; Lu X; Deng XF; Yang H; Zheng H; Qiu Y
Cancer Med; 2018 Mar; 7(3):809-819. PubMed ID: 29441725
[TBL] [Abstract][Full Text] [Related]
6. ADAM Metallopeptidase Domain 12 Facilitates Colorectal Cancer Progression by Inhibiting Hippo Signaling Pathway Activity.
Wang X; Zhu M; Zuo H; Hou G; Xie R
Mol Cancer Res; 2023 Jun; 21(6):525-534. PubMed ID: 36806444
[TBL] [Abstract][Full Text] [Related]
7. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
[TBL] [Abstract][Full Text] [Related]
8. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
9. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
[TBL] [Abstract][Full Text] [Related]
10. miR-338-3p suppresses colorectal cancer proliferation and progression by inhibiting MACC1.
Zou T; Duan J; Liang J; Shi H; Zhen T; Li H; Zhang F; Dong Y; Han A
Int J Clin Exp Pathol; 2018; 11(4):2256-2267. PubMed ID: 31938338
[TBL] [Abstract][Full Text] [Related]
11. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer.
Ten Hoorn S; Waasdorp C; van Oijen MGH; Damhofer H; Trinh A; Zhao L; Smits LJH; Bootsma S; van Pelt GW; Mesker WE; Mol L; Goey KKH; Koopman M; Medema JP; Tuynman JB; Zlobec I; Punt CJA; Vermeulen L; Bijlsma MF
BMC Cancer; 2022 Apr; 22(1):394. PubMed ID: 35413826
[TBL] [Abstract][Full Text] [Related]
12. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
Zhu Z; Hou Q; Guo H
Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
[TBL] [Abstract][Full Text] [Related]
13. Circ-0104631 promotes cell proliferation and invasion in colorectal cancer and predicts poor prognosis.
Cao JZ; Ma LM; Zhang YL; Guo HC; Niu X; Zhao TB
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4730-4737. PubMed ID: 31210299
[TBL] [Abstract][Full Text] [Related]
14. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
[TBL] [Abstract][Full Text] [Related]
15. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
16. A role for ADAM12 in breast tumor progression and stromal cell apoptosis.
Kveiborg M; Fröhlich C; Albrechtsen R; Tischler V; Dietrich N; Holck P; Kronqvist P; Rank F; Mercurio AM; Wewer UM
Cancer Res; 2005 Jun; 65(11):4754-61. PubMed ID: 15930294
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of SOX18 in colorectal cancer cells promotes proliferation and correlates with colorectal cancer risk.
Miao Z; Deng X; Shuai P; Zeng J
Onco Targets Ther; 2018; 11():8481-8490. PubMed ID: 30555240
[TBL] [Abstract][Full Text] [Related]
18. An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.
Luo ML; Zhou Z; Sun L; Yu L; Sun L; Liu J; Yang Z; Ran Y; Yao Y; Hu H
Cancer Lett; 2018 May; 422():118-128. PubMed ID: 29476791
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
[TBL] [Abstract][Full Text] [Related]
20. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
